Literature DB >> 14732906

Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes.

Naomi Lowe1, Aiveen Kirley, Ziarih Hawi, Pak Sham, Harvey Wickham, Christopher J Kratochvil, Shelley D Smith, Saretta Y Lee, Florence Levy, Lindsey Kent, Fiona Middle, Luis A Rohde, Tatiana Roman, Eda Tahir, Yanke Yazgan, Philip Asherson, Jonathan Mill, Anita Thapar, Antony Payton, Richard D Todd, Timothy Stephens, Richard P Ebstein, Iris Manor, Cathy L Barr, Karen G Wigg, Richard J Sinke, Jan K Buitelaar, Susan L Smalley, Stan F Nelson, Joseph Biederman, Stephen V Faraone, Michael Gill.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable, heterogeneous disorder of early onset, consisting of a triad of symptoms: inattention, hyperactivity, and impulsivity. The disorder has a significant genetic component, and theories of etiology include abnormalities in the dopaminergic system, with DRD4, DAT1, SNAP25, and DRD5 being implicated as major susceptibility genes. An initial report of association between ADHD and the common 148-bp allele of a microsatellite marker located 18.5 kb from the DRD5 gene has been followed by several studies showing nonsignificant trends toward association with the same allele. To establish the postulated association of the (CA)(n) repeat with ADHD, we collected genotypic information from 14 independent samples of probands and their parents, analyzed them individually and, in the absence of heterogeneity, analyzed them as a joint sample. The joint analysis showed association with the DRD5 locus (P=.00005; odds ratio 1.24; 95% confidence interval 1.12-1.38). This association appears to be confined to the predominantly inattentive and combined clinical subtypes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732906      PMCID: PMC1181932          DOI: 10.1086/381561

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  45 in total

1.  Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study.

Authors:  A Payton; J Holmes; J H Barrett; T Hever; H Fitzpatrick; A L Trumper; R Harrington; P McGuffin; M O'Donovan; M Owen; W Ollier; J Worthington; A Thapar
Journal:  Am J Med Genet       Date:  2001-07-08

Review 2.  Genetic basis of attention deficit and hyperactivity.

Authors:  A Thapar; J Holmes; K Poulton; R Harrington
Journal:  Br J Psychiatry       Date:  1999-02       Impact factor: 9.319

3.  Familiality and heritability of subtypes of attention deficit hyperactivity disorder in a population sample of adolescent female twins.

Authors:  R D Todd; E R Rasmussen; R J Neuman; W Reich; J J Hudziak; K K Bucholz; P A Madden; A Heath
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

4.  An adoption study of attention deficit/hyperactivity/aggression and their relationship to adult antisocial personality.

Authors:  R J Cadoret; M A Stewart
Journal:  Compr Psychiatry       Date:  1991 Jan-Feb       Impact factor: 3.735

Review 5.  Animal models of attention-deficit hyperactivity disorder.

Authors:  Eugen Davids; Kehong Zhang; Frank I Tarazi; Ross J Baldessarini
Journal:  Brain Res Brain Res Rev       Date:  2003-04

Review 6.  Attention-deficit/hyperactivity disorder in adults: an overview.

Authors:  S V Faraone; J Biederman; T Spencer; T Wilens; L J Seidman; E Mick; A E Doyle
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

Review 7.  Long-term prognosis in attention-deficit/hyperactivity disorder.

Authors:  S Mannuzza; R G Klein
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2000-07

8.  Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity.

Authors:  I D Waldman; D C Rowe; A Abramowitz; S T Kozel; J H Mohr; S L Sherman; H H Cleveland; M L Sanders; J M Gard; C Stever
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

9.  Recent genetic advances in ADHD and diagnostic and therapeutic prospects.

Authors:  Ziarih Hawi; Aiveen Kirley; Naomi Lowe; Michael Fitzgerald; Michael Gill
Journal:  Expert Rev Neurother       Date:  2003-07       Impact factor: 4.618

Review 10.  The Child and Adolescent Psychiatric Assessment (CAPA).

Authors:  A Angold; M Prendergast; A Cox; R Harrington; E Simonoff; M Rutter
Journal:  Psychol Med       Date:  1995-07       Impact factor: 7.723

View more
  44 in total

1.  The Wuerzburg Research Initiative on Adult Attention-Deficit/Hyperactivity Disorder (WURIN-AADHD): multi-layered evaluation of long-term course.

Authors:  Christian Jacob; Klaus-Peter Lesch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09       Impact factor: 5.270

Review 2.  Subtypes of attention-deficit/hyperactivity disorder (ADHD): distinct or related disorders across measurement levels?

Authors:  Dieter Baeyens; Herbert Roeyers; Johan Vande Walle
Journal:  Child Psychiatry Hum Dev       Date:  2006

3.  [In memory of Lev L'vovich Kiselev].

Authors:  A A Bogdanov; V G Debabov
Journal:  Mol Biol (Mosk)       Date:  2008 Sep-Oct

4.  Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.

Authors:  W Retz; M Rösler; C Kissling; S Wiemann; R Hünnerkopf; A Coogan; J Thome; C Freitag
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

Review 5.  The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder.

Authors:  Stephen V Faraone
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-02       Impact factor: 4.785

6.  Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder.

Authors:  Kate Langley; Tom A Fowler; Deborah L Grady; Robert K Moyzis; Peter A Holmans; Marianne B M van den Bree; Michael J Owen; Michael C O'Donovan; Anita Thapar
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-06-18       Impact factor: 4.785

Review 7.  Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Authors:  Tanya E Froehlich; James J McGough; Mark A Stein
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 8.  Genetic aspects in attention-deficit/hyperactivity disorder.

Authors:  O Albayrak; S Friedel; B G Schimmelmann; A Hinney; J Hebebrand
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

9.  Attention-Deficit Hyperactivity Disorder in the post-genomic era.

Authors:  Philip Asherson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

10.  Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11.

Authors:  Matthew N Ogdie; Simon E Fisher; May Yang; Janeen Ishii; Clyde Francks; Sandra K Loo; Rita M Cantor; James T McCracken; James J McGough; Susan L Smalley; Stanley F Nelson
Journal:  Am J Hum Genet       Date:  2004-08-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.